These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3517273

  • 1. Cephalosporin therapeutics in cystic fibrosis.
    Blumer JL, Stern RC, Yamashita TS, Myers CM, Reed MD.
    J Pediatr; 1986 May; 108(5 Pt 2):854-60. PubMed ID: 3517273
    [Abstract] [Full Text] [Related]

  • 2. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G, Agostini M, Barlocco G, Bonomi U, Borgo G, Bozzino L, Cabrini G, Cappelletti LM, Castellani L, Conforti M.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [Abstract] [Full Text] [Related]

  • 3. Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin.
    Møller NE, Koch C, Vesterhauge S, Jensen K.
    Scand J Infect Dis; 1982 Jul; 14(3):207-11. PubMed ID: 6815787
    [Abstract] [Full Text] [Related]

  • 4. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR.
    Clin Pharm; 1984 Jul; 3(4):373-85. PubMed ID: 6380902
    [Abstract] [Full Text] [Related]

  • 5. Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Padoan R, Brienza A, Crossignani RM, Lodi G, Giunta A, Assael BM, Granata F, Passarella E, Vallaperta PA, Xerri L.
    J Pediatr; 1983 Aug; 103(2):320-4. PubMed ID: 6348228
    [Abstract] [Full Text] [Related]

  • 6. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. British Thoracic Society Research Committee.
    Thorax; 1985 May; 40(5):358-63. PubMed ID: 2862713
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E, Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of superinfections caused by pyocyanic bacillus in patients with mucoviscidosis. Efficacy of cefsulodin in combination with an aminoglycoside].
    Jehanne M.
    Pathol Biol (Paris); 1989 May; 37(5):500-3. PubMed ID: 2780107
    [Abstract] [Full Text] [Related]

  • 9. Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response.
    Kercsmar CM, Stern RC, Reed MD, Myers CM, Murdell D, Blumer JL.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():289-95. PubMed ID: 6352634
    [Abstract] [Full Text] [Related]

  • 10. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
    Zobell JT, Waters CD, Young DC, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG.
    Pediatr Pulmonol; 2013 Feb; 48(2):107-22. PubMed ID: 22949297
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis with high or conventional doses of ceftazidime.
    De Boeck K, Breysem L.
    J Antimicrob Chemother; 1998 Mar; 41(3):407-9. PubMed ID: 9578170
    [Abstract] [Full Text] [Related]

  • 12. Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Stenvang Pedersen S, Pressler T, Pedersen M, Høiby N, Friis-Møller A, Koch C.
    Scand J Infect Dis; 1986 Mar; 18(2):133-7. PubMed ID: 3518048
    [Abstract] [Full Text] [Related]

  • 13. Cefsulodin sodium therapy in cystic fibrosis patients.
    Cabezudo I, Thompson RL, Selden RF, Guenthner SH, Wenzel RP.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):4-6. PubMed ID: 6422844
    [Abstract] [Full Text] [Related]

  • 14. Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.
    Scully BE, Neu HC.
    Arch Intern Med; 1984 Jan; 144(1):57-62. PubMed ID: 6419690
    [Abstract] [Full Text] [Related]

  • 15. Aminoglycosides and renal magnesium homeostasis in humans.
    von Vigier RO, Truttmann AC, Zindler-Schmocker K, Bettinelli A, Aebischer CC, Wermuth B, Bianchetti MG.
    Nephrol Dial Transplant; 2000 Jun; 15(6):822-6. PubMed ID: 10831634
    [Abstract] [Full Text] [Related]

  • 16. Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies.
    Cullen RT, McCrae WM, Govan J, Raeburn JA, Ingram TM.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():369-75. PubMed ID: 6352647
    [Abstract] [Full Text] [Related]

  • 17. [Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].
    Prévotat A, Leroy S, Perez T, Wallet F, Wallaert B.
    Rev Mal Respir; 2010 May; 27(5):449-56. PubMed ID: 20569877
    [Abstract] [Full Text] [Related]

  • 18. Ceftazidime disposition in acute and stable cystic fibrosis.
    Leeder JS, Spino M, Isles AF, Tesoro AM, Gold R, MacLeod SM.
    Clin Pharmacol Ther; 1984 Sep; 36(3):355-62. PubMed ID: 6432400
    [Abstract] [Full Text] [Related]

  • 19. Cystic fibrosis, intravenous antibiotics, and home therapy.
    Hammond LJ, Caldwell S, Campbell PW.
    J Pediatr Health Care; 1991 Sep; 5(1):24-30. PubMed ID: 1990112
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.